MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cardfail.2025.07.020

Медицинская библиотека · Journal of cardiac failure · 2025

Comparison of Heart Failure Cardiogenic Shock Patients with Axillary and Femoral Intra-aortic Balloon Pump: Cardiogenic Shock Working Group report.

Bhimaraj Arvind, Garan Arthur R, Kong Qiuyue, Kim J U, Pahuja Mohit, Kochar Ajar, Narayangowda Smitha, Li Borui, Li Song, Sinha Shashank S, Hickey Gavin W, Kataria Rachna, Ton VAN-Khue, Lundgren Scott, Nathan Sandeep, Vorovich Esther, Hall Shelley, Khalife Wissam, Schwartzman Andrew, Vishnevsky Oleg Alec, Zweck Elric, Fried Justin, Farr Mary Jane, Mahr Claudius, Mishkin Joseph, Chiang I-Hui, Ilonze Onyedika, Arias Alexandra, Marbach Jeffrey, Bezerra Hiram, Sangal Paavni, Walec Karol D, Zazzali Peter, Harwani Neil M, Blumer Vanessa, John Kevin, Hernandez-Montfort Jaime, Abraham Jacob, Burkhoff Daniel, Kanwar Manreet K, Kapur Navin K

СтатьяСравнительное исследованиеМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

IABPs traditionally are placed via the femoral artery. Single-center studies have shown the utility of axillary placement to promote ambulation. The utility of Ax IABP in CS has not been established. Therefore, we sought to describe the outcomes of patients receiving axillary (Ax) intra-aortic balloon pump (IABP) and compare them with those receiving femoral (Fem) IABP for heart failure-related cardiogenic shock (HF-CS).

METHODS

Data from 2020 to 2023 from the Cardiogenic Shock Working Group, a multicenter academic consortium, were analyzed. We examined the demographic, metabolic, hemodynamic characteristics, and outcomes of patients with HF-CS treated with Ax-IABP and compared them with those who primarily received a Fem-IABP.

RESULTS

Of 6201 CS patients in the registry, 557 (8.9%) patients received an IABP for HF-CS, of whom 244 (43.8%) and 313 (56.2%) received Ax-IABP and Fem-IABP, respectively. Compared with Fem-IABP, patients who received Ax-IABP were more likely to have previous intracardiac defibrillators (42.5% vs 68.9%, P < .001). Time to IABP implant from admission (7.9 ± 10.6 vs 1.8 ± 6.1, P < .01) and duration of support (9.6 ± 14.6 vs 4.0 ± 4.5, P < .01) were longer among Ax-IABP, relative to Fem-IABP. Patients who received Ax-IABP were more likely to undergo heart-replacement therapy (65% vs 21%, P < .001) compared with the Fem-IABP cohort. The rate of reported complications was similar between the 2 groups.

CONCLUSION

Axillary IABP is being used beyond single-center reports to support HF-CS mostly as a bridge to heart-replacement therapies. Its use might provide advantages over fem-IABP.

Для цитирования: Bhimaraj Arvind, Garan Arthur R, Kong Qiuyue, Kim J U, Pahuja Mohit, Kochar Ajar, Narayangowda Smitha, Li Borui, Li Song, Sinha Shashank S, Hickey Gavin W, Kataria Rachna, Ton VAN-Khue, Lundgren Scott, Nathan Sandeep, Vorovich Esther, Hall Shelley, Khalife Wissam, Schwartzman Andrew, Vishnevsky Oleg Alec, Zweck Elric, Fried Justin, Farr Mary Jane, Mahr Claudius, Mishkin Joseph, Chiang I-Hui, Ilonze Onyedika, Arias Alexandra, Marbach Jeffrey, Bezerra Hiram, Sangal Paavni, Walec Karol D, Zazzali Peter, Harwani Neil M, Blumer Vanessa, John Kevin, Hernandez-Montfort Jaime, Abraham Jacob, Burkhoff Daniel, Kanwar Manreet K, Kapur Navin K. Comparison of Heart Failure Cardiogenic Shock Patients with Axillary and Femoral Intra-aortic Balloon Pump: Cardiogenic Shock Working Group report.. Journal of cardiac failure. 2025. DOI: 10.1016/j.cardfail.2025.07.020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.